United States · 
Who invested in Vessix Vascular?
Vessix Vascular's investors include NeoMed, OrbiMed, Edmond de Rothschild Venture Capital and Fjord Invest.
2011
$4.7MVenture$23MSeries BUnited States · Series B startup
Who invested in Vessix Vascular
2 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$28Mraised across 2 rounds since 2010, from 2 sources
$4.7MVenture$23MSeries B
- Latest round
- Series B, $23MAug 2011
- Step-upi
- 4.9×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Venture, $4.7M Oct 2010
- Biggest round
- $23M Series B · Aug 2011
- Between rounds
- 9 months from the last two
The rounds
- Aug 2011Series B$23M3 new1 returning
Reported by finsmes.com
- Oct 2010
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
The exit
ExitBuyerPriceWhen
From historical deal records. Wrong? Tell us.
Everyone who backed them
NeoMedGrowth equity2rounds
Edmond de Rothschild Venture CapitalGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Vessix Vascular
How much has Vessix Vascular raised?
Vessix Vascular has raised $28M across 2 rounds since 2010.
When did Vessix Vascular last raise?
Vessix Vascular's most recent round was a Series B of $23M in Aug 2011.
What was Vessix Vascular's biggest round?
Its most recent round, $23M in Aug 2011, is also its largest on record.
Who backed Vessix Vascular first?
Vessix Vascular's first round on record, in Oct 2010, was backed by NeoMed.
What stage is Vessix Vascular at?
Vessix Vascular's latest named round is a Series B, in Aug 2011.
Where is Vessix Vascular based?
Vessix Vascular is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.